BWM
ORTX

Bulltick Wealth Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Bulltick Wealth Management’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,520
Closed -$58K – 165
2021
Q3 		$58K Buy
2,520
+1,000
+66% +$29.8K 0.01% 140
2021
Q2 		$66.7K Hold
1,520
– – 0.02% 138
2021
Q1 		$110K Sell
1,520
-668
-31% -$47.4K 0.03% 115
2020
Q4 		$94.5K Buy
+2,188
New +$98K 0.03% 102

Other funds holding ORTX

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Bulltick Wealth Management's ORTX Position: Q4 2021 in Review

Bulltick Wealth Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2021, closing a stake of 2,520 shares — an estimated $58K sold.

Bulltick Wealth Management first reported a position in ORTX in Q4 2020 and held it in 4 quarters. The position peaked at $110K in Q1 2021. 72 funds tracked by Wall St. Rank hold ORTX as of Q4 2021.

  • Bulltick Wealth Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Bulltick Wealth Management sold 2,520 Orchard Therapeutics plc American Depositary Shares shares in Q4 2021, an estimated $58K.
  • Bulltick Wealth Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2020 and held it in 4 quarters.
  • Bulltick Wealth Management's Orchard Therapeutics plc American Depositary Shares position peaked at $110K in Q1 2021.
  • 72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2021.

Based on Bulltick Wealth Management's 13F filing for Q4 2021, filed 25 Apr 2024.